Search

Illumina, Bill Gates & Jeff Bezos launched startup GRAIL to develop blood-based cancer tests

The test, which is also called as liquid biopsy, will use high-speed DNA sequencing machines to scour a person’s blood for fragments of DNA released by cancer cells.

Jan 12, 2016 15:56 IST
facebook IconTwitter IconWhatsapp Icon

Illumina, the world’s largest DNA sequencing company, on 10 January 2016 announced the launch of the startup named GRAIL to develop blood-based cancer tests.

The company was launched in association with Microsoft co-founder Bill Gates, Amazon CEO Jeff Bezo’s venture fund Bezos Expeditions and Arch Venture Partners.

Details related to Illumina

• The company will develop blood tests that cost 1000 US dollars or less for detecting many types of cancer before symptoms arise.
• The test, which is also called as liquid biopsy, will use high-speed DNA sequencing machines to scour a person’s blood for fragments of DNA released by cancer cells.
• All the partners in the startup raised around 100 million US dollars among themselves, in which Illumina will have the majority stake holder.
• The newly developed tests are expected to reach the market by 2019.
• GRAIL will operate from San Diego in California, the USA.

Now get latest Current Affairs on mobile, Download # 1  Current Affairs App

 

Download our Current Affairs & GK app For exam preparation

डाउनलोड करें करेंट अफेयर्स ऐप एग्जाम की तैयारी के लिए

AndroidIOS